David Southwell
Direktor/Vorstandsmitglied bei ROCKET PHARMACEUTICALS, INC.
Vermögen: 4 Mio $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von David Southwell
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues.
254
| Extinct | Investment Banks/Brokers | 254 |
| Public Company | Pharmaceuticals: Major | 66 | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.
43
| Subsidiary | Pharmaceuticals: Major | 43 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.
30
| Subsidiary | Medical Specialties | 30 |
| Public Company | Biotechnology | 29 | |
| Public Company | Biotechnology | 21 | |
BioSphere Medical, Inc.
 BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA.
17
| Subsidiary | Medical Specialties | 17 |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA.
17
| Extinct | Pharmaceuticals: Major | 17 |
| Private Eq Fd/Alt Invt | Investment Managers | 13 | |
| Public Company | Biotechnology | 12 | |
THL Credit Secured Floating Rate Debt Ltd.
 THL Credit Secured Floating Rate Debt Ltd. Financial ConglomeratesFinance THL Credit Secured Floating Rate Debt, Ltd. operates as a closed-end management investment company. It is managed by THL Credit Advisors LLC, which provides the administrative services. The company intends to elect to be treated as a business development company. THL Credit Secured Floating Rate Debt was founded on June 26, 2013 and is headquartered in Boston, MA.
7
| Private Company | Financial Conglomerates | 7 |
Sensorium Therapeutics, Inc.
 Sensorium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sensorium Therapeutics, Inc. is a biotechnology company based in Massachusetts. Sensorium Therapeutics leverages cutting-edge chemistry, neuroscience, and machine learning to develop nature-inspired psychoactive medicines for mental health. The American company's groundbreaking biodynamic discovery platform™ rapidly identifies, reproduces, adapts, and enhances targeted molecules to deliver transformational benefits to patients around the world. The company completed a $30m series A financing in late 2023 led by Santé Ventures, with participation from Route 66 Ventures, CU Healthcare Innovation Fund, and others. The company was founded by Jerrold F. Rosenbaum, Jacob Hooker, Richard Simon, Alex Simon, and Stephen Haggarty. Richard Simon has been the CEO since incorporation.
4
| Holding Company | Pharmaceuticals: Major | 4 |
inVentiv Health, Inc.
 inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA.
4
| Extinct | Miscellaneous Commercial Services | 4 |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Panel Intelligence LLC
 Panel Intelligence LLC Internet Software/ServicesTechnology Services Panel Intelligence LLC offers a powerful online health care and medical research platform providing clients greater strategic direction for investment decisions, product development, and marketing. The private company is based in Cambridge, MA. William J. Febbo has been the CEO of the company since 2009. Panel Intelligence was acquired by Panel Intelligence /Private Group/ from Merriman Holdings, Inc. on January 30, 2009 for $1.10 million.
1
| Private Company | Internet Software/Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David Southwell
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Human Resources Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Washington University in St. Louis | College/University | Doctorate Degree Doctorate Degree | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| REGENXBIO INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer President | |
First Eagle Alternative Credit LLC
 First Eagle Alternative Credit LLC Investment ManagersFinance First Eagle Alternative Credit LLC (FEAC) is an independent, SEC-registered investment advisor headquartered in Boston, Massachusetts with offices in Chicago, Dallas, Los Angeles, and New York. The firm was founded in 2007 under the name THL Credit Advisors LLC. They are a wholly-owned subsidiary of First Eagle Investment Management LLC, which is owned by First Eagle Holdings, Inc. FEAC provides advisory services to many types of clients including BDCs, insurance companies, banks, corporations, pension and profit-sharing plans, trusts and estates, charitable organizations, mutual funds, closed-end funds, government entities, pooled investment vehicles, and private investment funds. | Investment Managers | Chief Executive Officer Chief Executive Officer Director of Finance/CFO President Compliance Officer Compliance Officer | |
| AVIDITY BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Brown University | College/University | Graduate Degree Undergraduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Analyst General Counsel Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Doctorate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| The University of Manchester | College/University | Undergraduate Degree Undergraduate Degree | |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal Director of Finance/CFO | |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Undergraduate Degree Masters Business Admin | |
| Yale University | College/University | Doctorate Degree Doctorate Degree | |
| University of the Sciences in Philadelphia | College/University | Director/Board Member Doctorate Degree | |
| Robert Wood Johnson Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
THL Credit Group LP
 THL Credit Group LP Investment ManagersFinance THL Credit Group LP (THL Credit) is a private equity subsidiary of Thomas H. Lee Partners LP founded in 2007. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Chief Executive Officer President Director of Finance/CFO Chief Executive Officer Private Equity Investor | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SunAmerica Corporate Finance | President Corporate Officer/Principal | ||
| VERASTEM, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| CLEARPOINT NEURO, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
First Eagle Alternative Credit SLS LLC
 First Eagle Alternative Credit SLS LLC Investment ManagersFinance First Eagle Alternative Credit SLS LLC (FEAC) is an investment advisory firm headquartered in Boston, Massachusetts. The firm was founded in 2012 as THL Credit Senior Loan Strategies LLC. They are a subsidiary of First Eagle Alternative Credit LLC and their ultimate parent is First Eagle Holdings, Inc. | Investment Managers | Chief Executive Officer President General Counsel | |
The Tennessee Center For Research & Development
 The Tennessee Center For Research & Development BiotechnologyHealth Technology The Tennessee Center For Research & Development operates as a research and development center for biotechnology. The company was founded on July 31, 1984 is headquartered in Knoxville, TN. | Biotechnology | Chief Executive Officer President General Counsel | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| The University of Chicago Law School | College/University | Graduate Degree Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Yale College | College/University | Undergraduate Degree Undergraduate Degree | |
Thl Credit Lakeshore, Inc.
 Thl Credit Lakeshore, Inc. Financial ConglomeratesFinance Thl Credit Lakeshore, Inc. is an investment holding company. It invest primarily in secured loans consist of first lien, including unitranche facilities and to a lesser extent, second lien facilities. The company was founded on September 30, 1950 and is headquartered in Boston, MA. | Financial Conglomerates | Chief Executive Officer Director of Finance/CFO Chief Executive Officer General Counsel | |
RTW Investments /Venture/
 RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Investment Managers | Chief Investment Officer Private Equity Investor Private Equity Investor | |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Biotechnology | Chairman Founder | |
ImmuneID, Inc.
 ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer | |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| New York University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 47 |
| Vereinigtes Königreich | 3 |
| Israel | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 18 |
| Finance | 9 |
| Commercial Services | 5 |
Operativ
| Director/Board Member | 480 |
| Corporate Officer/Principal | 249 |
| Independent Dir/Board Member | 157 |
| Chairman | 93 |
| Undergraduate Degree | 81 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Glenn Steele | 54 |
| Argeris Karabelas | 42 |
| Jerome Zeldis | 38 |
| James Hunt | 34 |
| Christoph Westphal | 32 |
| Michael Schmertzler | 29 |
| Timothy Barberich | 28 |
| Mark Iwicki | 26 |
| Katina Dorton | 22 |
| David Keith Downes | 22 |
| Michael Bell | 22 |
| Ittai Harel | 22 |
| Deborah McAneny | 21 |
| Roger Norman Freeman | 20 |
| Adrian Adams | 19 |
- Börse
- Insiders
- David Southwell
- Unternehmensverbindungen
